NO20080162L - Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer - Google Patents

Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer

Info

Publication number
NO20080162L
NO20080162L NO20080162A NO20080162A NO20080162L NO 20080162 L NO20080162 L NO 20080162L NO 20080162 A NO20080162 A NO 20080162A NO 20080162 A NO20080162 A NO 20080162A NO 20080162 L NO20080162 L NO 20080162L
Authority
NO
Norway
Prior art keywords
compounds
flt3
tienopyrimidine
flt
kinase inhibitors
Prior art date
Application number
NO20080162A
Other languages
English (en)
Norwegian (no)
Inventor
Michael David Gaul
Kevin Douglas Kreutter
Christian Andrew Baumann
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20080162L publication Critical patent/NO20080162L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20080162A 2005-06-10 2008-01-09 Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer NO20080162L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68971005P 2005-06-10 2005-06-10
US74694106P 2006-05-10 2006-05-10
PCT/US2006/022151 WO2006135639A1 (en) 2005-06-10 2006-06-07 Thiξnopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors

Publications (1)

Publication Number Publication Date
NO20080162L true NO20080162L (no) 2008-03-07

Family

ID=37074647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080162A NO20080162L (no) 2005-06-10 2008-01-09 Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer

Country Status (19)

Country Link
US (3) US20060281768A1 (pt)
EP (1) EP1899355A1 (pt)
JP (1) JP2008543759A (pt)
KR (1) KR20080021126A (pt)
AR (1) AR057063A1 (pt)
AU (1) AU2006258049A1 (pt)
BR (1) BRPI0613644A2 (pt)
CA (1) CA2611587A1 (pt)
CR (1) CR9650A (pt)
EA (1) EA200800011A1 (pt)
EC (1) ECSP077992A (pt)
IL (1) IL187689A0 (pt)
MX (1) MX2007015741A (pt)
NI (1) NI200700311A (pt)
NO (1) NO20080162L (pt)
PE (1) PE20070070A1 (pt)
TW (1) TW200716651A (pt)
UY (1) UY29590A1 (pt)
WO (1) WO2006135639A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
JP2009534454A (ja) * 2006-04-25 2009-09-24 アステックス、セラピューティックス、リミテッド 医薬化合物
WO2007125321A2 (en) 2006-04-25 2007-11-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
EP2066642A1 (en) * 2006-09-25 2009-06-10 Arete Therapeutics, INC. Soluble epoxide hydrolase inhibitors
TW200924781A (en) 2007-09-14 2009-06-16 Janssen Pharmaceutica Nv Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
BRPI0818533B8 (pt) 2007-10-11 2021-05-25 Astrazeneca Ab composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
ME03589B (me) 2011-04-01 2020-07-20 Astrazeneca Ab Terapeutski tretman
NZ618795A (en) 2011-05-13 2015-07-31 Array Biopharma Inc Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
MX367640B (es) 2011-11-30 2019-08-29 Astrazeneca Ab Tratamiento combinado del cáncer.
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
CN106459013B (zh) 2014-05-15 2019-10-25 阵列生物制药公司 作为trka激酶抑制剂的化合物及其用途
US10806737B2 (en) 2016-12-23 2020-10-20 Arvinas Operations, Inc. Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
KR101954370B1 (ko) 2018-07-25 2019-03-05 한미약품 주식회사 피리미딘 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물
ES2974634T3 (es) 2018-12-21 2024-06-28 Celgene Corp Inhibidores de tienopiridinas de RIPK2
BR112021016522A2 (pt) 2019-02-22 2021-10-26 Hanmi Pharm. Co., Ltd. Composição farmacêutica para o tratamento da leucemia mieloide aguda
EP3991733A4 (en) 2019-06-27 2023-07-05 Hanmi Pharm. Co., Ltd. Pharmaceutical composition for treating acute myeloid leukemia, containing flt3 inhibitor and chemotherapeutic agents
EP4719355A1 (en) * 2023-05-31 2026-04-08 Hanmi Pharm. Co., Ltd. Solid dispersion of myeloid kinome inhibitors and pharmaceutical composition comprising the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1306095A3 (en) * 1992-03-05 2003-06-25 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
US5932765A (en) * 1997-05-23 1999-08-03 Merck Patent Gesellschaft Mit Nitromethyl ketones, process for preparing them and compositions containing them
SK6652000A3 (en) * 1997-11-11 2002-05-09 Pfizer Prod Inc Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
YU47600A (sh) * 1998-01-27 2002-09-19 Aventis Pharmaceuticals Products Inc. SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF
US6776796B2 (en) * 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
TWI238824B (en) * 2001-05-14 2005-09-01 Novartis Ag 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
US7105505B2 (en) * 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
NZ538713A (en) * 2002-08-12 2007-01-26 Takeda Chemical Industries Ltd Fused benzene derivative and use
WO2004039782A1 (ja) * 2002-10-29 2004-05-13 Kirin Beer Kabushiki Kaisha Ｆｌｔ３自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US20060281769A1 (en) * 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators

Also Published As

Publication number Publication date
MX2007015741A (es) 2008-04-29
IL187689A0 (en) 2008-08-07
TW200716651A (en) 2007-05-01
WO2006135639A1 (en) 2006-12-21
CA2611587A1 (en) 2006-12-21
NI200700311A (es) 2009-03-03
KR20080021126A (ko) 2008-03-06
AU2006258049A1 (en) 2006-12-21
CR9650A (es) 2008-09-09
BRPI0613644A2 (pt) 2011-01-25
US20060281768A1 (en) 2006-12-14
EP1899355A1 (en) 2008-03-19
ECSP077992A (es) 2008-01-23
EA200800011A1 (ru) 2008-06-30
US20090163710A1 (en) 2009-06-25
JP2008543759A (ja) 2008-12-04
AR057063A1 (es) 2007-11-14
UY29590A1 (es) 2006-10-02
PE20070070A1 (es) 2007-03-08
US20090143378A1 (en) 2009-06-04
AU2006258049A8 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
NO20080168L (no) Aminoquinolin- og aminoquinoazolinkinasemodulatorer
NO20083013L (no) Triazolopyridaziner som tyrosinkinasemodulatorer
NO20080174L (no) Alkylquinolin- og alkylquinazolinkinasemodulatorer
NO20080163L (no) Aminopyrimidiner som kinasemodulatorer
NO20080161L (no) Aminopyrimidiner som kinasemodulatorer
NO20061194L (no) Mitotiske kinesininbibitorer
EA200870373A1 (ru) Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ
CR9650A (es) Derivados de tienopirimidina y tienopiridina como inhibidores de tirosina cinasa 3 tipo fms
EA201101583A1 (ru) Ингибиторы pi3 киназы или mtor
EA201000366A1 (ru) Производные 2-бифениламино-4-аминопиримидина в качестве ингибиторов киназ
NO20023831L (no) Pyrrol substituert 2-indolinonproteinkinaseinhibitorer
NO20070506L (no) Fremgangsmater og mellomprodukter nyttige for fremstilling av kondenserte heterocykliske kinase inhibitorer.
MY156536A (en) Inhibitors of protein tyrosine kinase activity
MX2009003650A (es) Nuevos imidazotiazoles e imidazoxazoles.
EA200970486A1 (ru) Соединения для ингибирования митоза
NO20090608L (no) Tyrosinkinaseinhibitorer
NO20080417L (no) Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET
MX2010007927A (es) Derivados de 4-(pirrolo[2,3-c]piridin-3-il)pirimidin-2-ilamina.
EA201001576A1 (ru) Тиенопиримидины
ATE502935T1 (de) C-met-proteinkinasehemmer
NZ630353A (en) Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
UA109764C2 (uk) Похідні ізохінолінону, композиція на їх основі та застосування як інгібіторів рі3k

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application